DOYLE THOMAS JAMES Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$101,721.35

Insider Activity of DOYLE THOMAS JAMES

According to the SEC Form 4 filings, DOYLE THOMAS JAMES, being in a position of

  1. SVP, Finance & Accounting at Kura Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16288 shares for $159,519,
    over all time since 2023-01-27, has bought 0 shares, and sold 29644 shares for $301,847.

Biography of DOYLE THOMAS JAMES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $159,5193100

Comparison of Insiders on Amount of Buys and Sells

2026-09-28SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
4,607
0.0051%
$10.50$48,361-4.62%
2026-01-27SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
7,142
0.0082%
$8.46$60,426+12.99%
2025-11-14SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
4,539
0.0055%
$11.18$50,732-12.71%
2025-09-29SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
4,541
0.0052%
$8.94$40,607+9.03%
2025-01-28SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
4,949
0.0064%
$7.87$38,958+0.9%
2024-01-29SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
2,318
0.003%
$17.80$41,262+7.47%
2023-01-27SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
1,548
0.0023%
$13.89$21,502-19.32%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.